Meet The Latest Radiopharmaceuticals Player
Sanofi and Orano Med have kicked off a joint venture worth $1.9bn to develop alpha-emitting cancer therapies, underscoring the importance of this space to big pharma.
Sanofi and Orano Med have kicked off a joint venture worth $1.9bn to develop alpha-emitting cancer therapies, underscoring the importance of this space to big pharma.